First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    Imara Inc.

    IRON · 2 developments mapped · last assessed 2026-09-01

    Market Ontology has mapped 2 macro, policy, and market developments to Imara Inc. since 2026-09-01. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for IRON yet, so no modelled value is shown. The IRON valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run IRON on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for IRON. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Open question

      Disc Medicine to Present Phase 2 Hematology Data at SOHO 2026

      Indirect competitive landscape shift in hematologic disorders, particularly myelofibrosis, if DISC-0974 data is compelling.

      · Moves competitive intensity in myelofibrosis market, market share potential for competing therapies

    What changed, by assumption

    Competitive intensity in myelofibrosis market
    • 2026-09-01Disc Medicine to Present Phase 2 Hematology Data at SOHO 2026
    Market share for competing therapies
    • 2026-09-01Disc Medicine to Present Phase 2 RESTORE-PV and RALLY-MF Trial Data at SOHO

    Assumption changes

    Full ledger →
    DateAssumptionDirectionWhyConf.
    2026-06-30Cost of capitalBullishHigher cost-of-debt tranche lifts blended WACC.0.70
    2026-06-30Interest expenseBullishHigh-yield coupon materially raises interest burden.0.70
    2026-06-30Net debtBullishSub-IG debt raise increases leverage and net debt.0.70

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-09-01Disc Medicine to Present Phase 2 Hematology Data at SOHO 2026watch1-3m0.40
    2026-09-01Disc Medicine to Present Phase 2 RESTORE-PV and RALLY-MF Trial Data at SOHOwatch1-3m0.30